Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | FABP1 | P07148 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7091675 | 0.84 | CTNNB1 (0.55) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL7170195 | 0.83 | CTNNB1 (0.42) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL16645442 | 0.78 | CTNNB1 (0.47) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL1879537 | 0.77 | LMNA (0.50) | KDM4EMAPTALDH1A1HPGDTSHR | |
| SCHEMBL1355519 | 0.77 | ALDH1A1 (0.55) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL27437859 | 0.77 | CTNNB1 (0.46) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL698742 | 0.74 | KDM4E (0.61) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL21579477 | 0.74 | KDM4E (0.53) | CTNNB1KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL17157291 | 0.73 | ALDH1A1 (0.48) | KDM4EMAPTALDH1A1HPGDHSD17B10 | |
| SCHEMBL10335126 | 0.73 | L3MBTL1 (0.50) | CTNNB1KDM4EMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10315185-B2 | Polyfunctional sorbent materials | UNIVERSITY OF OREGON (US) | 2019-06-11 | — | — | US | claimed |
| US-20180015442-A1 | POLYFUNCTIONAL SORBENT MATERIALS | UNIVERSITY OF OREGON (US) | 2018-01-18 | — | — | US | claimed |
| US-10315185-B2 | Polyfunctional sorbent materials | UNIVERSITY OF OREGON (US) | 2019-06-11 | — | — | US | disclosed |
| US-20180015442-A1 | POLYFUNCTIONAL SORBENT MATERIALS | UNIVERSITY OF OREGON (US) | 2018-01-18 | — | — | US | disclosed |
| US-20100147768-A1 | RENEWABLE SORBENT MATERIAL AND METHOD OF USE | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF UNIVERSITY | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180015442-A1 | POLYFUNCTIONAL SORBENT MATERIALS | EPCAM, SELPLG, SPR | CTNNB1 3464/4885KDM4E 2093/4885MAPT 2292/4885 |
| US-10315185-B2 | Polyfunctional sorbent materials | EPCAM, SELPLG, SPR | CTNNB1 3464/4885KDM4E 2093/4885MAPT 2292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.